12/18/2024
5:49 PM | Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:05 PM | Recursion Pharmaceuticals (Filer)
| Form 424B7 | |
12/17/2024
4:06 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
3:48 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024
4:46 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
9:29 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2024
9:32 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
12/03/2024
3:40 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2024
6:02 PM | Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/27/2024
3:09 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K/A | |
11/26/2024
3:48 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K/A | |
11/22/2024
5:25 PM | Michor Franziska (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/22/2024
5:25 PM | Michor Franziska (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
6:11 AM | Recursion Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/20/2024
6:14 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2024
5:26 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
5:26 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
5:26 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
5:26 PM | Mauro David J (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
5:52 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
6:19 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
6:19 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
3:34 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2024
9:11 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2024
8:22 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
3:57 PM | Recursion Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/12/2024
1:48 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/06/2024
3:18 PM | Recursion Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
5:05 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
5:12 AM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
11/04/2024
3:16 PM | Kinnevik AB (0001766574) (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/04/2024
12:27 PM | Recursion Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
8:46 AM | BAILLIE GIFFORD & CO (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
10/31/2024
5:01 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
4:20 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
10/29/2024
3:35 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/28/2024
4:25 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2024
3:22 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
Buy this coin BEFORE Inauguration Day … (Ad) Mark my words … Bitcoin is going to $100,000.
BEFORE Trump is inaugurated.
And I think it could reach $125,000 by the end of his first month in office. This could be his favorite coin. |
10/18/2024
9:59 AM | Recursion Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/17/2024
4:27 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2024
4:15 PM | Burrell Terry-Ann (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024
3:42 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2024
5:40 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
5:00 AM | Recursion Pharmaceuticals (Filer)
| Form DEFM14A | |
10/09/2024
3:23 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024
3:19 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/04/2024
5:29 PM | Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
5:30 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
5:30 PM | Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
5:30 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:58 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
9:27 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
12:31 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
7:03 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
1:20 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024
5:15 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/26/2024
3:14 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2024
4:48 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
3:27 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
09/17/2024
5:03 AM | Recursion Pharmaceuticals (Filer)
| Form PREM14A | |
09/12/2024
5:28 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
4:15 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
4:00 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2024
3:57 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
4:25 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
10:43 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
4:24 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
09/04/2024
12:16 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
3:48 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:27 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
7:01 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
7:02 AM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
08/30/2024
3:26 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:53 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
3:49 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
08/27/2024
3:10 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
3:42 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:25 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
5:48 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:25 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
6:09 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:09 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:09 PM | Mauro David J (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:09 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
4:24 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:35 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
3:22 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024
3:19 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
Could This Tiny Device Help You Make an Extra $30k a Year? (Ad) I believe it’s going to power Elon Musk’s next AI revolution…
A revolution he believes will be worth more than $9 trillion.
That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. Click here to see the details because I believe a lot of people will get rich. |
08/08/2024
4:23 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
11:56 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024
7:05 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
7:09 AM | Recursion Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
7:10 AM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
08/07/2024
12:34 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/06/2024
3:50 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/29/2024
5:16 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
5:15 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
